BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 21569425)

  • 1. Review of the 25th annual scientific meeting of the International Society for Biological Therapy of Cancer.
    Balwit JM; Kalinski P; Sondak VK; Coulie PG; Jaffee EM; Gajewski TF; Marincola FM
    J Transl Med; 2011 May; 9():60. PubMed ID: 21569425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immuno-oncology biomarkers 2010 and beyond: perspectives from the iSBTc/SITC biomarker task force.
    Butterfield LH; Disis ML; Khleif SN; Balwit JM; Marincola FM
    J Transl Med; 2010 Dec; 8():130. PubMed ID: 21138581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The iSBTc/SITC primer on tumor immunology and biological therapy of cancer: a summary of the 2010 program.
    Balwit JM; Hwu P; Urba WJ; Marincola FM
    J Transl Med; 2011 Jan; 9():18. PubMed ID: 21281484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conference scene: Immune signatures in the tumor and beyond.
    Kandalaft LE; Kalos M; Melief CJ; Speiser DE; Coukos G
    Immunotherapy; 2012 Aug; 4(8):761-72. PubMed ID: 22947003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18th Annual Scientific Meeting of the International Society for Biological Therapy of Cancer. 30 October-2 November 2003, Bethesda, Maryland, USA.
    Marincola FM; Wang E; Atkins MB
    Expert Opin Biol Ther; 2004 Jan; 4(1):107-14. PubMed ID: 14680473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highlights of the 31st annual meeting of the Society for Immunotherapy of Cancer (SITC), 2016.
    Gulley JL; Repasky EA; Wood LS; Butterfield LH
    J Immunother Cancer; 2017 Jul; 5(1):55. PubMed ID: 28716068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pioneering the trail of cancer immunotherapy.
    Kotlan B; Balwit JM
    Expert Rev Anticancer Ther; 2011 Mar; 11(3):351-4. PubMed ID: 21417850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop.
    Bedognetti D; Ceccarelli M; Galluzzi L; Lu R; Palucka K; Samayoa J; Spranger S; Warren S; Wong KK; Ziv E; Chowell D; Coussens LM; De Carvalho DD; DeNardo DG; Galon J; Kaufman HL; Kirchhoff T; Lotze MT; Luke JJ; Minn AJ; Politi K; Shultz LD; Simon R; Thórsson V; Weidhaas JB; Ascierto ML; Ascierto PA; Barnes JM; Barsan V; Bommareddy PK; Bot A; Church SE; Ciliberto G; De Maria A; Draganov D; Ho WS; McGee HM; Monette A; Murphy JF; Nisticò P; Park W; Patel M; Quigley M; Radvanyi L; Raftopoulos H; Rudqvist NP; Snyder A; Sweis RF; Valpione S; Zappasodi R; Butterfield LH; Disis ML; Fox BA; Cesano A; Marincola FM;
    J Immunother Cancer; 2019 May; 7(1):131. PubMed ID: 31113486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Cancer Immunotherapy Agents in Development: a report from an associated program of the 31
    Adusumilli PS; Cha E; Cornfeld M; Davis T; Diab A; Dubensky TW; Evans E; Grogan JL; Irving BA; Leidner RS; Olwill SA; Soon-Shiong P; Triebel F; Tuck D; Bot A; Dansey RD; Drake CG; Freeman GJ; Ibrahim R; Patel S; Chen DS
    J Immunother Cancer; 2017; 5():50. PubMed ID: 28649381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Summary of the primer on tumor immunology and the biological therapy of cancer.
    Li Y; Liu S; Margolin K; Hwu P
    J Transl Med; 2009 Jan; 7():11. PubMed ID: 19175928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New horizons in bladder cancer research.
    Boormans JL; Zwarthoff EC; Black PC; Goebell PJ; Kamat AM; Nawroth R; Seiler R; Williams SB; Schmitz-Dräger BJ
    Urol Oncol; 2020 Dec; 38(12):867-885. PubMed ID: 30852032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: online resources and useful tools - a compass in the land of biomarker discovery.
    Bedognetti D; Balwit JM; Wang E; Disis ML; Britten CM; Delogu LG; Tomei S; Fox BA; Gajewski TF; Marincola FM; Butterfield LH
    J Transl Med; 2011 Sep; 9():155. PubMed ID: 21929757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Workshop on challenges, insights, and future directions for mouse and humanized models in cancer immunology and immunotherapy: a report from the associated programs of the 2016 annual meeting for the Society for Immunotherapy of cancer.
    Zloza A; Karolina Palucka A; Coussens LM; Gotwals PJ; Headley MB; Jaffee EM; Lund AW; Sharpe AH; Sznol M; Wainwright DA; Wong KK; Bosenberg MW
    J Immunother Cancer; 2017 Sep; 5(1):77. PubMed ID: 28923102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision.
    Emens LA; Romero PJ; Anderson AC; Bruno TC; Capitini CM; Collyar D; Gulley JL; Hwu P; Posey AD; Silk AW; Wargo JA
    J Immunother Cancer; 2024 Jun; 12(6):. PubMed ID: 38901879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CIMT 2018: Pushing frontiers in cancer immunotherapy - Report on the 16
    Beck J; Birtel M; Reidenbach D; Salomon N; Diken M
    Hum Vaccin Immunother; 2018; 14(12):2864-2873. PubMed ID: 30111232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 16th Annual Scientific Meeting of the Society for Biological Therapy. 8 - 11 November 2001, Bethesda, Maryland, USA.
    Dillman RO; Dillman JB
    Expert Opin Biol Ther; 2002 Feb; 2(2):223-7. PubMed ID: 12170947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers.
    Butterfield LH; Palucka AK; Britten CM; Dhodapkar MV; Håkansson L; Janetzki S; Kawakami Y; Kleen TO; Lee PP; Maccalli C; Maecker HT; Maino VC; Maio M; Malyguine A; Masucci G; Pawelec G; Potter DM; Rivoltini L; Salazar LG; Schendel DJ; Slingluff CL; Song W; Stroncek DF; Tahara H; Thurin M; Trinchieri G; van Der Burg SH; Whiteside TL; Wigginton JM; Marincola F; Khleif S; Fox BA; Disis ML
    Clin Cancer Res; 2011 May; 17(10):3064-76. PubMed ID: 21558394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SITC 26th annual meeting--summary.
    Romano E; Nardelli-Haefliger D; Donda A; Corgnac S; Romero P
    J Transl Med; 2012 May; 10():105. PubMed ID: 22620286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From a Patient Advocate's Perspective: Does Cancer Immunotherapy Represent a Paradigm Shift?
    Madden DL
    Curr Oncol Rep; 2018 Feb; 20(1):8. PubMed ID: 29411148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter to the editor: Checking the pulse of adoptive cell therapy for solid tumors. Thoughts from the abstracts submitted to the 35th Annual Meeting of the Society for the Immunotherapy of Cancer (SITC 2020).
    Markovska M; Marincola F
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33419860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.